Bio

Robert LeBoyer joined Noble Capital Markets in 2021 to cover the Biotechnology and Specialty Pharmaceuticals industry. Mr. LeBoyer began his research career at Prudential Securities, and has previously been a Senior Biotechnology Analyst at Brown Brothers Harriman and Leerink Swann, joining Noble from Ladenburg Thalmann. Robert holds a BA in Economics from Tulane University and an MBA from Columbia Business School.